
April 24 (Reuters) - Coya Therapeutics Inc COYA.O:
COYA THERAPEUTICS ANNOUNCES POSITIVE INTERIM RESULTS OF AN INVESTIGATOR-INITIATED OPEN LABEL STUDY WITH LOW-DOSE IL-2 AND CTLA4-IG COMBINATION TREATMENT IN FIVE PATIENTS WITH MILD TO MODERATE FRONTOTEMPORAL DEMENTIA
COYA THERAPEUTICS INC - STUDY SHOWS SIGNIFICANT INCREASE IN TREG NUMBERS AND FUNCTION
COYA THERAPEUTICS INC - FTD PATIENTS SHOW MINIMAL TO NO COGNITIVE DECLINE IN STUDY